At a short odds guess :- What they'll be promoting!
"Albany, NY -- (SBWIRE) -- 06/01/2016 -- In Europe, approximately 70% of the total population suffers from vitamin D deficiency, of which barely 5-6% has undergone vitamin D testing. This indicates that the vitamin D testing market in Europe is unpenetrated and has a high potential since the market has a large patient pool. Major vendors in Europe understand the potential market scenario and are constantly investing in R&D and innovating vitamin D testing devices, and assays and kits that will provide an accurate result at low cost.
Growing vitamin D deficiency will lead to various acute and chronic diseases such as cancer and asthma if not detected at an early stage and can be fatal for a patient. Thus, prevention of these fatal diseases is considered one of the major drivers contributing to the growth of the vitamin D testing market in Europe. Technavio expects the vitamin D testing market in Europe to grow at a steady rate, posting a CAGR of more than 5% during the forecast period.
Segmentation of the vitamin D testing market in Europe by application
- 25-hydroxy vitamin D test
- 1, 25-dihydroxy vitamin D test
With a massive share of 77% in 2014, the 25-hydroxy vitamin D test segment held the majority of the vitamin D testing market in Europe, and this trend is expected to continue during the forecast period. The 25-hydroxy test is the most commonly used test to detect levels of vitamin D in the body.
Competitive landscape and key vendors
The European market for vitamin D appears attractive from the vendors' perspective as a major part of the market is untapped. Therefore, there is robust competition among the vendors to develop products with high accuracy and efficiency through constant investment in R&D and innovation in the market.
Top vendors in this market are -
- Abbott Diagnostics
- bioMerieux
- DiaSorin
- Fujirebio Diagnostics
- Roche Diagnostics
- Siemens Healthcare
Other prominent vendors included in this report are SCIEX Diagnostics, Diazyme Laboratories, Biokit, City Assays, Tosoh Bioscience Inc., Qualigen Inc., Dade Behring, DIAsource ImmunoAssays S.A, Ortho-Clinical Diagnostics, Biorad Laboratories, Piramal Healthcare, Beckman Coulter, and Becton Dickinson."
Read more: http://m.digitaljournal.com/pr/2959487#ixzz4BH8T8RPW
- Forums
- ASX - By Stock
- ADO
- diasource-ado to exhibit in paris expo 22nd-24th
diasource-ado to exhibit in paris expo 22nd-24th, page-22
Featured News
Add ADO (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $49.79M |
Open | High | Low | Value | Volume |
2.1¢ | 2.1¢ | 2.0¢ | $3.965K | 195.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 1417631 | 2.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.1¢ | 95237 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
15 | 1417631 | 0.020 |
11 | 2115460 | 0.019 |
6 | 2437947 | 0.018 |
5 | 1724748 | 0.017 |
1 | 420000 | 0.016 |
Price($) | Vol. | No. |
---|---|---|
0.021 | 95237 | 1 |
0.022 | 325988 | 5 |
0.023 | 540459 | 7 |
0.024 | 141966 | 2 |
0.025 | 409646 | 5 |
Last trade - 14.20pm 11/10/2024 (20 minute delay) ? |
Featured News
ADO (ASX) Chart |